Absci (ABSI) News
NASDAQ: ABSIHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ABSI news summary
We found 12 recent headlines mentioning Absci (ABSI): 0 in the past week and 10 in the past 30 days, most often from Nasdaq, GlobeNewswire, Seeking Alpha. ABSI is making an outsized move today, down 7.97% at $7.51, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Absci anticipates interim 13-week ABS-201 pattern hair loss data next month as it plans mid-2027 endometriosis Phase 2 start", was published by Seeking Alpha on Nov 12, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Absci headlines
- Absci anticipates interim 13-week ABS-201 pattern hair loss data next month as it plans mid-2027 endometriosis Phase 2 startSeeking Alpha
- Absci (ABSI) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaqABSI, LEN.B
- Absci Corp Q3 Sales Decline(RTTNews) - Absci Corp (ABSI) announced Loss for third quarter of -$33.300 millionNasdaqABSI, BF.A
- Absci GAAP EPS of -$0.19 in-line, revenue of $0.3M misses by $0.28MSeeking Alpha
- Absci Reports Business Updates and Third Quarter 2026 Financial and Operating ResultsABS-201™ HEADLINE™ trial progressing on track; 13-week interim proof-of-concept data for pattern hair loss (PHL) anticipated next monthGlobeNewswire
- Absci Appoints Gerry Muhle as Chief Commercial Officer to Build Category-Defining Brands for ABS-201 and Its Broader PipelineGlobal commercial executive brings a track record of launching prescription biologics and building consumer-driven brands at Galderma, Allergan and GSK Global commercial executive brings a track…GlobeNewswire
- Absci Q3 2026 Earnings PreviewSeeking Alpha
- Jefferies Initiates Coverage of Absci with BuyFintel reports that on October 29, 2026, Jefferies initiated coverage of Absci (NASDAQGS:ABSI) with a Buy recommendation. This initiation occurred alongside a pre-action close of $11.89 on October…NasdaqABSI, MOG.B
- ARKG, TXG, TEM, ABSI: ETF Outflow AlertLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ARK Genomic Revolution ETF (Symbol: ARKG) where we have detected an…NasdaqARKG, TXG, TEM, ABSI
- Absci to Participate in Upcoming Investor ConferencesVANCOUVER, Wash. and NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with…GlobeNewswire
- Wednesday's ETF Movers: WSML, KWEBIn trading on Wednesday, the iShares MSCI World Small-Cap ETF is outperforming other ETFs, up about 3.7% on the day. Components of that ETF showing particular strength include shares of Absci, up…NasdaqABSI, TXG, TAL, YMM
- Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026VANCOUVER, Wash. and NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with…GlobeNewswire